Kaya Ozen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kaya Ozen has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Ahmet Gorgel
Department of Endocrinology and Metabolism Selcuk University Faculty of Medicine Konya Turkey
1 shared publication - Barış Yaylak
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Education Research Hospital, Istanbul - Turquia
1 shared publication - Bernas Altıntaş
Department of Cardiology, Gazi Yaşargil Training and Research Hospital, Diyarbakır, Turkey
1 shared publication Berzal Ucaman
Department of Cardiology, Diyarbakir Gazi Yasargil Education and Research Hospital, Malatya, Turkey
1 shared publication- Cegerğun Polat1 shared publication
- Erkan Baysal
Department of Cardiology, Diyarbakır Gazi Yaşargil Education and Research Hospital, Diyarbakır, Turkey
1 shared publication
Latest Publications
- 9 September 2020
- Published by Turkiye Kalp Ve Saglik Vakfi Iktisadi Isletmesi in e-Journal of Cardiovascular Medicine
- Vol. 8 (3) , 123-130
The Relation Between Thyroid Stimulating Hormone and Left Ventricular Strain Parameters in Patients with Subclinical Hypothyroidism
- 9 September 2020
- Published by Turkiye Kalp Ve Saglik Vakfi Iktisadi Isletmesi in e-Journal of Cardiovascular Medicine
- Vol. 8 (3) , 123-130
The Relation Between Thyroid Stimulating Hormone and Left Ventricular Strain Parameters in Patients with Subclinical Hypothyroidism
- Open Access
- 1 August 2015
- Published by Taylor & Francis in Therapeutics and Clinical Risk Management
- Vol. 11, 1187-1191
The relationship between eosinophilia and slow coronary flow
Aim: The pathophysiology of slow coronary flow (SCF) involves atherosclerosis, small vessel dysfunction, platelet function disorders, and inflammation. It has been known that eosinophils also play a significant role in inflammation, vasoconstriction, thrombosis, and endothelial dysfunction. We propose to evaluate the relationship between eosinophilia and SCF. Methods: All patients who underwent coronary angiography between January 2011 and December 2013 were screened retrospectively. Of 6,832 patients, 102 patients with SCF (66 males, mean age 52.2±11.7 years) and 77 control subjects with normal coronary angiography (50 males, mean age 50.7±8.1 years) were detected. Baseline characteristics, hematological test results, and biochemical test results were obtained from the hospital database. Results: Baseline characteristics of the study groups were comparable between groups. There was no significant difference between groups regarding leukocyte count, paletelet count, and mean platelet volume. However, patients with SCF had a higher eosinophil count than the controls (0.24±0.17×103/µL vs 0.16±0.15×103/µL, P=0.002). In addition, eosinophil count was found to be correlated with thrombolysis in myocardial infarction (TIMI) frame count in the SCF group (r=0.3, P Conclusion: Patients with SCF have higher blood eosinophil count, and this may play an important role in the pathogenesis of SCF. Elevated baseline eosinophil count may indicate the presence of SCF.
- 1 August 2015
- Published by Taylor & Francis in Therapeutics and Clinical Risk Management
- Vol. 11, 1187-1191
Open AccessThe relationship between eosinophilia and slow coronary flow
Aim: The pathophysiology of slow coronary flow (SCF) involves atherosclerosis, small vessel dysfunction, platelet function disorders, and inflammation. It has been known that eosinophils also play a significant role in inflammation, vasoconstriction, thrombosis, and endothelial dysfunction. We propose to evaluate the relationship between eosinophilia and SCF. Methods: All patients who underwent coronary angiography between January 2011 and December 2013 were screened retrospectively. Of 6,832 patients, 102 patients with SCF (66 males, mean age 52.2±11.7 years) and 77 control subjects with normal coronary angiography (50 males, mean age 50.7±8.1 years) were detected. Baseline characteristics, hematological test results, and biochemical test results were obtained from the hospital database. Results: Baseline characteristics of the study groups were comparable between groups. There was no significant difference between groups regarding leukocyte count, paletelet count, and mean platelet volume. However, patients with SCF had a higher eosinophil count than the controls (0.24±0.17×103/µL vs 0.16±0.15×103/µL, P=0.002). In addition, eosinophil count was found to be correlated with thrombolysis in myocardial infarction (TIMI) frame count in the SCF group (r=0.3, P Conclusion: Patients with SCF have higher blood eosinophil count, and this may play an important role in the pathogenesis of SCF. Elevated baseline eosinophil count may indicate the presence of SCF.